Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age55-85
SponsorUniversity of Southern California

About this trial

This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrain, maintain balance during putting and squat-like tasks. Physical activity and exercise are beneficial to physical function, cognitive function, psychosocial health, and overall quality of life during prostate cancer survivorship. These aspects of health are impacted by prostate cancer treatment, especially androgen deprivation therapy. Additionally, supervised, group-based activity programs facilitate participation in physical activity. Researchers want to examine the changes in functional abilities, psychosocial health, and quality of life following participation in in a golf program designed for prostate cancer survivors.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

First time, primary diagnosis of prostate cancer (PCa)

Currently receiving androgen deprivation therapy (ADT) and/or androgen receptor blocker) for more than 6 months

Older adult male: 55-85 years old

The ability to stand independently without external support

Disqualifiers

Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases

Prostatectomy less than 6 months prior to study enrollment (prostatectomy is not a requirement for study entry)

Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (systolic blood pressure (SBP) > 160 or diastolic blood pressure (DBP) > 90, high resting pulse heart rate (HR) > 90), symptomatic orthostatic hypotension

Unstable asthma, exacerbated chronic obstructive pulmonary disease (COPD]

Trial design

Design model

Single group

Treatments tested in this trial

  • Biospecimen Collection

    Procedure/Surgery

    Undergo blood sample collection

  • Discussion

    Procedure/Surgery

    Ancillary studies

  • Exercise Intervention

    Other intervention

    Complete golf related exercises

  • Interview

    Other intervention

    Ancillary studies

  • Medical Device Usage and Evaluation

    Other intervention

    Wear activity tracker

  • Physical Examination

    Procedure/Surgery

    Ancillary studies

  • Physical Performance Testing

    Other intervention

    Ancillary studies

  • Questionnaire Administration

    Other intervention

    Ancillary studies

  • Recreational Therapy

    Other intervention

    Participate in golf program

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: Supportive care (golf program)Experimental treatment 9 interventions

Trial outcomes

Primary outcomes

1

Enrollment rate

Will be defined as the final number of enrolled individuals / the number of qualified individuals screened.

Time frame
Up to 3 years
2

Participant adherence to the program

Will be assessed by the number of participants who adhere to the study and attend \> 80% of supervised training sessions.

Time frame
Up to 3 years
3

Cost of the program

Will be assessed by the cost that the program will be \< $1,000/participant.

Time frame
Up to 3 years
4

Staff adherence

Will be assessed by trained staff who attend \> 90% of scheduled sessions.

Time frame
Up to 3 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Southern California

Lead sponsor

National Cancer Institute (NCI)

Collaborator